Weiss Multi-Strategy Advisers’s Aratana Therapeutics, Inc. PETX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-175,000
Closed -$630K 693
2019
Q1
$630K Buy
175,000
+25,000
+17% +$108K 0.02% 423
2018
Q4
$920K Sell
150,000
-5,000
-3% -$30.5K 0.04% 307
2018
Q3
$905K Buy
155,000
+20,000
+15% +$99.9K 0.02% 407
2018
Q2
$574K Buy
135,000
+35,000
+35% +$176K 0.01% 483
2018
Q1
$441K Buy
100,000
+40,000
+67% +$178K 0.01% 470
2017
Q4
$316K Hold
60,000
0.01% 520
2017
Q3
$368K Hold
60,000
0.01% 447
2017
Q2
$434K Sell
60,000
-5,000
-8% -$30.7K 0.02% 462
2017
Q1
$345K Buy
65,000
+5,000
+8% +$33.8K 0.01% 496
2016
Q4
$431K Hold
60,000
0.02% 341
2016
Q3
$562K Sell
60,000
-1,965
-3% -$16.3K 0.03% 335
2016
Q2
$392K Sell
61,965
-29,035
-32% -$187K 0.03% 342
2016
Q1
$502K Hold
91,000
0.02% 388
2015
Q4
$508K Hold
91,000
0.04% 305
2015
Q3
$770K Buy
91,000
+1,000
+1% +$16.9K 0.03% 284
2015
Q2
$1.36M Buy
90,000
+23,500
+35% +$339K 0.05% 295
2015
Q1
$1.06M Buy
66,500
+6,500
+11% +$116K 0.05% 312
2014
Q4
$1.07M Buy
60,000
+30,000
+100% +$374K 0.04% 277
2014
Q3
$301K Buy
30,000
+5,000
+20% +$60.6K 0.01% 475
2014
Q2
$390K Hold
25,000
0.01% 561
2014
Q1
$464K Buy
+25,000
New +$501K 0.01% 682

Other funds holding PETX

Weiss Multi-Strategy Advisers's PETX Position: Q2 2019 in Review

Weiss Multi-Strategy Advisers sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2019, closing a stake of 175,000 shares — an estimated $630K sold.

Weiss Multi-Strategy Advisers first reported a position in PETX in Q1 2014 and held it in 21 quarters. The position peaked at $1.36M in Q2 2015. 103 funds tracked by Wall St. Rank hold PETX as of Q2 2019.

  • Weiss Multi-Strategy Advisers reported no remaining Aratana Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 175,000 Aratana Therapeutics, Inc. shares in Q2 2019, an estimated $630K.
  • Weiss Multi-Strategy Advisers first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 21 quarters.
  • Weiss Multi-Strategy Advisers's Aratana Therapeutics, Inc. position peaked at $1.36M in Q2 2015.
  • 103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.